TLIS

Talis Biomedical Corporation Common Stock

TLIS

Market cap $7.98M

Delisted

TLIS was delisted on the 30th of August, 2024.

35 hedge funds and large institutions have $12.1M invested in Talis Biomedical Corporation Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 15 closing their positions.

Upgrade to unlock

New

Increased

Maintained

Reduced

Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

–

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

Net Calls Change

Top Buyers

1		+$300K
2		+$213K
3		+$96.1K
4	E Ergoteles New York	+$73.2K
5	Mercer Global Advisors Denver, Colorado	+$72.2K

Top Sellers

1		-$965K
2		-$757K
3		-$212K
4	Geode Capital Management Boston, Massachusetts	-$127K
5	Northern Trust Chicago, Illinois	-$101K

#	Name	Holding
26	26	$1K
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–
46	46	–
47	47	–
48	48	–
49	49	–

#	Name	Holding
26	26	$1K
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–
46	46	–
47	47	–
48	48	–
49	49	–

#	Name	Holding
26	26	$1K
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–
46	46	–
47	47	–
48	48	–
49	49	–

Talis Biomedical Corporation Common Stock TLIS Market cap $7.98M